MedPath

Probiotics Supplementation Effect on Glucose Homeostasis in Children With Type 1 Diabetes

Not Applicable
Conditions
Diabetes Mellitus, Type 1
Interventions
Dietary Supplement: probiotics
Registration Number
NCT04579341
Lead Sponsor
Ain Shams University
Brief Summary

Background: Probiotics influence immune homeostasis, through altering gut microbiota. The efficacy of probiotics in diabetes has been shown in preclinical settings as well as in human trials. Interleukin (IL)-21 and IL22 have been implicated in the pathogenesis of T1D. Objectives: to assess the effect of oral supplementation with probiotics on glycemic control as well as IL-21 and IL-22 levels in children with T1D. Methods: This randomized-controlled trial study included 70 children with T1D. Enrolled children aged 5-18 years with disease duration \> 1 year. They were randomly assigned into two groups; intervention group (group A) who received oral probiotics containing Lactobacillus acidophilus La-14 (108 CFU) 0.5 mg once daily. The other group (group B) did not receive any supplementation and served as a control group. Both groups were followed-up for 6 months with assessment of fasting blood glucose (FBG), HbA1c, IL-21 and IL-22 levels.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • T1D
Read More
Exclusion Criteria
  • other types of DM
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
probiotics armprobioticsprobiotics administered in addition to insulin regimen
Primary Outcome Measures
NameTimeMethod
glycemic control6 months

HbA1C

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ain Shams University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath